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Comparison of 3He and 129Xe MRI
for Evaluation of Lung Microstructure
and Ventilation at 1.5T
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Background: To support translational lung MRI research with hyperpolarized 129Xe gas, comprehensive evaluation of derived
quantitative lung function measures against established measures from 3He MRI is required. Few comparative studies have
been performed to date, only at 3T, and multisession repeatability of 129Xe functional metrics have not been reported.
Purpose/Hypothesis: To compare hyperpolarized 129Xe and 3He MRI-derived quantitative metrics of lung ventilation
and microstructure, and their repeatability, at 1.5T.
Study Type: Retrospective.
Population: Fourteen healthy nonsmokers (HN), five exsmokers (ES), five patients with chronic obstructive pulmonary
disease (COPD), and 16 patients with nonsmall-cell lung cancer (NSCLC).
Field Strength/Sequence: 1.5T. NSCLC, COPD patients and selected HN subjects underwent 3D balanced steady-state
free-precession lung ventilation MRI using both 3He and 129Xe. Selected HN, all ES, and COPD patients underwent 2D
multislice spoiled gradient-echo diffusion-weighted lung MRI using both hyperpolarized gas nuclei.
Assessment: Ventilated volume percentages (VV%) and mean apparent diffusion coefficients (ADC) were derived from
imaging. COPD patients performed the whole MR protocol in four separate scan sessions to assess repeatability. Same-
day pulmonary function tests were performed.
Statistical Tests: Intermetric correlations: Spearman’s coefficient. Intergroup/internuclei differences: analysis of variance /
Wilcoxon’s signed rank. Repeatability: coefficient of variation (CV), intraclass correlation (ICC) coefficient.
Results: A significant positive correlation between 3He and 129Xe VV% was observed (r5 0.860, P< 0.001). VV% was
larger for 3He than 129Xe (P50.001); average bias, 8.79%. A strong correlation between mean 3He and 129Xe ADC was
obtained (r5 0.922, P< 0.001). MR parameters exhibited good correlations with pulmonary function tests. In COPD
patients, mean CV of 3He and 129Xe VV% was 4.08% and 13.01%, respectively, with ICC coefficients of 0.541 (P5 0.061)
and 0.458 (P5 0.095). Mean 3He and 129Xe ADC values were highly repeatable (mean CV: 2.98%, 2.77%, respectively;
ICC: 0.995, P<0.001; 0.936, P< 0.001).
Data Conclusion: 129Xe lung MRI provides near-equivalent information to 3He for quantitative lung ventilation and
microstructural MRI at 1.5T.
Level of Evidence: 3
Technical Efficacy: Stage 2
J. MAGN. RESON. IMAGING 2018;00:000–000.
The majority of hyperpolarized gas lung magnetic reso-nance imaging (MRI) studies that have been performed to date in patients with lung diseases have used
3He gas,
exploiting its intrinsically stronger MRI signal when
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compared to 129Xe. However, recent years have seen an
increase in 129Xe lung MRI1 studies in patients for assess-
ment of lung ventilation,2–5 microstructure,6,7 and regional
gas exchange8 with this naturally abundant isotope. This
renewed interest is attributable to the relative scarcity of
3He gas,9 and parallel developments in 129Xe gas polariza-
tion technology10–13 and MRI pulse sequences14 that have
helped bridge the gap in image quality due to the difference
in gyromagnetic ratio between the two nuclei.
Previous comparisons of the sensitivity of 3He and
129Xe MRI for assessment of lung ventilation and micro-
structure have been reported in healthy subjects, former
smokers,7 patients with chronic obstructive pulmonary dis-
ease (COPD),3,15 and asthma.16 Generally, lung ventilation
and microstructural information of similar diagnostic quality
has been obtained with the two nuclei, despite their differ-
ent diffusivity in the lung airspaces. However, all of these
reported studies were carried out at 3T, at relatively modest
spatial resolution (15mm and 30mm slice thickness for
ventilation and diffusion-weighted microstructural MRI,
respectively), and at a single site.3,7,15,16 Magnetic suscepti-
bility differences at 1.5T and 3T have been shown to have
some impact on lung ventilation and diffusion-weighted
microstructural MRI with both gases17,18; however, quanti-
tative information derived from 3He and 129Xe techniques
at the most-reported field strength to date for lung MRI
(1.5T) has yet to be systematically compared. This informa-
tion is critical for multisite implementation and widespread
clinical dissemination of 129Xe MRI in the future.
In addition, future clinical use of 129Xe will require
quantitative data regarding the repeatability and robustness
of associated MRI biomarkers of lung disease. The most
commonly reported quantitative metrics of lung ventilation
from conventional, static hyperpolarized gas images are per-
centage ventilated volume (VV%) and ventilation defect
percentage (VDP5 100% – VV%). Same-day 3He VDP
measurements were reported to be highly repeatable at 3T
in patients with COPD,19,20 while 1-week repeatability was
relatively poorer. Good same-day and same-week repeatabil-
ity of 3He VV% has been reported in cystic fibrosis (CF)
patients at 1.5T21 and 3T,22 respectively. One report of
high same-session repeatability of 129Xe VDP in healthy
subjects and asthma patients has been published recently23;
however, multisession, multiday variability in quantitative
lung ventilation metrics derived from 129Xe MRI has not
been assessed. Delivery of several doses of 129Xe gas for ven-
tilation imaging on the same/subsequent day to subjects
with a variety of pulmonary conditions has been
reported.2,24 However, the primary purpose of those studies
was to assess safety and tolerability, and ventilation volume
repeatability was not evaluated.
The global mean 3He apparent diffusion coefficient
(ADC) in the lung airspaces derived from diffusion-
weighted MRI is a well-established marker of alveolar
microstructural change. Comprehensive investigations of
same-session25 and multiday26 repeatability of mean 3He
ADC values have demonstrated a high intra-individual
repeatability in healthy subjects and patients with emphy-
sema. Furthermore, studies at 3T have highlighted a higher
repeatability of 3He ADC when compared to 3He VDP in
patients with COPD.19,20 However, to our knowledge,
interscan repeatability of 129Xe ADC has not been assessed
to date. Evaluation of the repeatability of lung ventilation
and microstructural metrics derived from 129Xe MRI against
3He MRI and pulmonary functional tests is therefore neces-
sary to facilitate the clinical dissemination of these methods.
Taking the gaps in the literature discussed above into
account, the purpose of this work was to evaluate the applica-
bility and repeatability of quantitative metrics of 129Xe ventila-
tion and diffusion-weighted MRI as compared to the
equivalent 3Hemeasurements made at a field strength of 1.5T.
Materials and Methods
Subjects
We present an analysis of MR data obtained from several distinct
studies. Two groups of healthy nonsmokers: a) 11 participants
(age5 436 6 years), and b) three participants (age5 316 4
years), all with no history of smoking or respiratory disorders; five
ex-smokers with a pack history of 10 years and no history of
respiratory disorders (age5 516 2 years); five patients with
COPD (GOLD stage: 3D [n5 4], 3B [n5 1]; age5 676 7
years); and 16 patients with nonsmall-cell lung cancer (NSCLC)
(age5 676 12 years) were recruited for separate studies approved
by the National Research Ethics Committee, with governance
approval from the local National Health Service research commit-
tee. All subjects provided written informed consent. Patient demo-
graphics and pulmonary function test (PFT) results are
summarized in Table 1. Subjects with a resting oxygen saturation
of <90%, unstable cardiac disease, or (for NSCLC patients)
comorbid conditions that precluded radiotherapy, were excluded.
MRI Technique
All subjects underwent MRI at 1.5T (GE HDx, GE Healthcare,
Milwaukee, WI). Flexible quadrature radiofrequency coils were
employed for transmission and reception of MR signals at the Lar-
mor frequencies of 3He and 129Xe (Clinical MR Solutions, Brook-
field, WI). 3He and 129Xe gas was polarized by collisional spin-
exchange optical pumping, using a prototype commercial 3He
polarizer (MITI, Durham, NC) (average polarization 25%) and
a home-built 129Xe polarizer12,27 (average polarization 10–15%),
respectively.
Patients with NSCLC and COPD, and three healthy non-
smokers (group b) underwent 3D lung ventilation MRI with a
steady-state free precession (SSFP) sequence at breath-hold after
inhalation of 3He or 129Xe gas.14,28 1H images of the thorax were
also acquired for anatomical reference and calculation of total lung
volume. As illustrated in Fig. 1 (right), 1H images were acquired
in both the same breath-hold29 and a separate breath-hold as 3He
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ventilation images (same breath-hold for ease of image registration;
separate breath-hold in case same breath-hold acquisition failed or
could not be registered). Due to the length of the 129Xe ventilation
imaging breath-hold, 1H images were acquired in a separate
breath-hold. VV% was derived by segmentation (and registration if
required) of paired sets of hyperpolarized gas and corresponding
1H images as described previously28 (VV%5 volume of
"ventilated" regions from segmentation of hyperpolarized gas
images / total lung volume from segmentation of 1H images). In
addition to calculation of VV%, images were qualitatively assessed
for size and number of ventilation defects (regions of unventilated
signal, defined as falling below 2 standard deviations of the noise)
and signal heterogeneity in ventilated areas. Hyperpolarized gas
and 1H pulse sequence parameters are listed in Table 2. In each
FIGURE 1: Left: Comparison of 3He and 129Xe MR ventilation images of i. a healthy nonsmoker (group b), ii. a patient with NSCLC
(white arrows indicate the location of a lesion), and iii. a patient with COPD. (Note: The slice thickness of 3He images is half that
of 129Xe images; see Table 2). Right: Corresponding breath-hold scheme for ventilation imaging scans. Scans were acquired in the
order shown, with a change of RF coil and repositioning of the patient between 3He and 129Xe scans.
TABLE 1. Summary of Subject Demographics, PFT Results, and 3He and 129Xe MRI Parameters
Subject group
Healthy nonsmokers
Parameter a b Healthy
ex-smokers
NSCLC
patients
COPD
patients
Age (yrs)
(# of Subjects)
43.06 6.4
(6M, 5F)
30.76 3.5
(3M)
51.06 2.3
(3M, 2F)
66.96 12.0
(10M, 6F)
67.46 6.5
(2M, 3F)
FEV1 (%-pred) 101.06 12.5 92.66 15.9 94.96 9.8 72.76 25.0 38.06 6.6
FEV1/FVC (%) 77.16 7.2 77.06 7.6 75.16 13.2 57.16 16.5 29.76 5.9
DLCO (%-pred) 89.66 17.8 102.36 9.3 103.56 16.2 56.66 31.0 42.56 32.4
3He VV% — 98.46 0.60 — 79.66 11.7 71.46 7.8
129Xe VV% — 96.66 0.32 — 70.86 13.3 59.86 10.4
3He ADCglob
(cm2.s21)
0.1906 0.017 — 0.2116 0.022 — 0.4326 0.127
129Xe ADCglob
(cm2.s21)
0.0386 0.003 — 0.0436 0.004 — 0.0736 0.019
FEV15 forced expiratory volume in 1 second; FVC5 forced vital capacity; DLCO5 diffusing capacity of the lung for carbon monox-
ide; %-pred5PFTs expressed as a percentage of a predicted value, based on the subject’s age, height, and other demographic factors.
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case, a dose of 3He (99.25% of 100% 3He isotope, 0.75% N2) or
129-enriched xenon (86% 129Xe) gas was balanced to 1 L with N2
in a Tedlar bag and inhaled via a sterilized air filter. Prior to image
acquisition, subjects inhaled from functional residual capacity
(FRC) after a period of steady breathing. Target inhaled gas doses
were achieved to within a tolerance of6 10mL for 3He and6
20mL for 129Xe. Images with a signal-to-noise ratio (SNR) of <5
were not included in quantitative analysis. This threshold was
determined by quantitative evaluation of the effect of SNR on ven-
tilation heterogeneity30 by incrementally adding noise to high SNR
ventilation images.
Healthy nonsmokers (group a), ex-smokers, and COPD
patients underwent 2D multislice 3He and 129Xe diffusion-
weighted lung MRI to acquire ADC maps of the lungs. ADC val-
ues were calculated from the first two interleaves of a multiple b-
value 2D diffusion-weighted spoiled gradient echo sequence.
Acquisition parameters and bipolar diffusion gradient timing
parameters are summarized in Table 2. Gradients were designed to
achieve comparable diffusion weighting for the two nuclei, and
slice locations were matched (with an additional anterior slice for
3He acquisitions). The same SNR threshold as ventilation imaging
was applied to diffusion-weighted MRI data. Note: Healthy non-
smokers (group a) and ex-smokers did not undergo ventilation
imaging in this study. Likewise, patients with NSCLC and healthy
group b did not undergo diffusion-weighted MRI.
Patients with COPD underwent the complete MR protocol
on four separate scan sessions in total: twice on day 1; once on day
2; and once 2 weeks after day 1, to assess the repeatability of 3He
and 129Xe metrics.
Pulmonary Function Testing
PFTs, including the diffusing capacity of the lung for carbon mon-
oxide (DLCO) and spirometry, were performed by each COPD
patient, once on the same day as each MR session (three times in
total, always following MRI). Healthy nonsmokers and ex-smokers
performed the same tests immediately after their single-timepoint
diffusion-weighted MR scans, and NSCLC patients performed
PFTs within 61 week of MRI.
Statistical Analysis
VV% and global mean ADC (ADCglob) values derived from
3He
and 129Xe MRI were compared for differences in each metric
TABLE 2. Summary of MR Pulse Sequence Acquisition Parameters
Metric 3He VV% 129Xe VV% 3He ADC 129Xe ADC
Pulse sequence 3He 3D
SSFP
1H 3D
SPGR
129Xe 3D
SSFP
1H 3D
SPGR
DW 2D
SPGR
DW 2D
SPGR
FOV (cm) 40 40 40 40 40 40
Phase FOV 0.8 1.0 0.8 1.0 0.75 0.75
Matrix 1003 80 1003 100 1003 80 1003 100 643 64 643 48
Pixel size (mm) 43 4 43 4 43 4 43 4 6.253 6.25 6.253 8.33
# of slices 48 48 24 24 5 4
Slice thickness
(mm)
5 5 10 10 15
(10mm gap)
15
(10mm gap)
Flip angle (8) 9 5 9/10a 5 4.8 6.7
TE/TR (msec) 0.6/1.9 0.6/1.9 2.2/6.7 0.6/1.9 4.8/10.0 12.5/27.0
BW(kHz) 683.3 683.3 68 683.3 631.25 62
Gas dose (ml) 200 N/A 600 N/A 300 600
Breath-hold (s) 5 4 14 4 16 16
14 (3He1gap11H) — — —
D (ms) — — 1.6 (s50.3; 5.0 (s50.3;
— — d51.0; X50) d53.0; X51.4)
ND — — 6 4
Gm (mT.m
21) — — 31.6 32.2
b1,2 (s.cm
22) — — 0; 1.6 0; 8.0
SSFP: steady-state free precession; SPGR: spoiled gradient echo; FOV: field of view; TE: echo time; TR: repetition time; BW: band-
width; D: diffusion time, s: ramp time, d: plateau time; X: separation of gradient lobes; ND: number of diffusion-weighted interleaves;
Gm: maximum gradient amplitude; b1,2: b values of first two interleaves.
FOV and ventilation # of slices were increased if necessary to cover the whole lungs of larger patients.
aFlip angle was 9 8 for COPD patients, 10 8 for NSCLC patients.
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between two, or more than two, subject groups with conventional t-
tests or analyses of variance (ANOVA), respectively. Differences in
metrics derived between gas nuclei were analyzed using Wilcoxon
signed rank tests. Spearman’s rank correlation coefficients were
derived to quantify the relationship between 3He and 129Xe data-
sets, and Bland–Altman analysis was used to visualize systematic
differences in VV% between the two nuclei. MRI metrics were
compared and correlated against PFT results by calculating Spear-
man’s rank coefficients. The mean of repeated measurements from
each COPD patient was used to represent a single datapoint for
the above statistical tests.
Where repeatability data were available, the coefficient of
variation (CV) of each parameter was calculated as the ratio of the
standard deviation (SD) to the mean over all repeated measure-
ments, expressed as a percentage. In addition, two-way mixed
intraclass correlation (ICC) coefficients were calculated for absolute
agreement between repeat measurements. Statistical analyses were
performed using IBM SPSS Statistics (v. 23, Armonk, NY) and R
(R3.4, R Foundation for Statistical Computing, Vienna, Austria),
and statistical significance level was set to P< 0.05.
Results
Imaging Data Quality
From the healthy nonsmokers cohort, 129Xe diffusion-
weighted MR images from one subject exhibited insufficient
SNR for accurate calculation of ADC maps. From the
COPD cohort, one 3He and one 129Xe ADC dataset, and
two 3He and two 129Xe VV% datasets (each out of a total
of 20 datasets for each nucleus, each metric) were either not
successfully acquired or image SNR was unsatisfactory.
From the NSCLC patient cohort, one 3He dataset and one
1H dataset was not acquired successfully, and two 129Xe
datasets showed low SNR.
All other recorded data were of sufficient SNR for
analysis: ie, for 3He, >95% of ADC data and >90% of
VV% data were acceptable; for 129Xe, 95% of ADC data
and >85% of VV% data were acceptable. All gas doses
were well-tolerated and no significant side effects or adverse
events were reported. Mean MR parameters and PFT results
are shown in Table 1.
Ventilation Imaging
Representative 3He and 129Xe coronal ventilation images
and corresponding structural 1H images from patients with
NSCLC and COPD are shown in Fig. 1 (left), alongside
images from a healthy nonsmoker. Considerable ventilation
abnormalities were observed in patients with NSCLC, with
most patients exhibiting a heterogeneous distribution of
ventilated airspaces and complete absences of ventilation in
the region of the lung associated with malignancies (as iden-
tified on structural 1H MRI). Severe ventilation defects were
detected in most COPD patients, and entire lobes of the
lungs were often observed to be completely unventilated.
By pooling data from healthy nonsmokers (group b)
and patients with NSCLC and COPD, a significant positive
correlation between 3He and 129Xe VV%, was identified
(Spearman’s correlation coefficient, r5 0.860, P< 0.001).
Derived VV% values were larger on average for 3He when
compared with 129Xe (mean over all healthy group b,
NSCLC, and COPD subjects); P< 0.001 (Wilcoxon signed
rank) and qualitatively, typically larger and more numerous
ventilation defects could be observed in 129Xe images. A
Bland–Altman plot of the systematic differences between
3He and 129Xe VV% is shown in Fig. 2, indicating a bias of
18.79% towards higher 3He VV%. Analyzing data from
COPD and NSCLC patients separately, intragroup correla-
tions between 3He and 129Xe VV% were statistically signifi-
cant for NSCLC patients (r5 0.657, P5 0.024) but not
COPD patients (r5 0.700, P5 0.233). Additionally, 3He
VV% values were found to be higher than 129Xe VV% val-
ues when COPD (P5 0.063, close to significant) and
NSCLC (P5 0.002, significant) patient data were analyzed
separately. There were no significant differences in either
mean 3He VV% (P5 0.095) or mean 129Xe VV%
(P5 0.085) values between the two patient groups, although
the VV% trended to be lower in COPD patients compared
with NSCLC patients.
Diffusion-Weighted Imaging
Examples of 3He and 129Xe ADC maps obtained from a
healthy nonsmoker and a patient with COPD are shown in
Fig. 3. ADCglob values of both nuclei were significantly ele-
vated in COPD patients when compared to both healthy non-
smokers (group a) and ex-smokers: 3He ADCglob5 0.4326
0.127 cm2.s21 in COPD patients, 0.2116 0.022 cm2.s21 in
FIGURE 2: Bland–Altman analysis of 3He and 129Xe VV% values
in patients with NSCLC and COPD and healthy nonsmokers
group b. The solid gray line indicates the mean difference
(bias) between 3He and 129Xe VV%, and dashed lines represent
61.96 standard deviations from the mean. Datapoints and
error bars for COPD patients denote intrasubject means and
standard deviations of repeated acquisitions, respectively.
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ex-smokers (P5 0.036 vs. COPD patients) and 0.1906
0.017 cm2.s21 in healthy nonsmokers (P5 0.028 vs. COPD
patients); mean 129Xe ADCglob5 0.0736 0.019 cm
2.s21 in
COPD patients, 0.0426 0.004 cm2.s21 in ex-smokers
(P5 0.045 vs. COPD patients) and 0.0386 0.003 cm2.s21 in
healthy nonsmokers (P5 0.029 vs. COPD patients). Ex-
smoker and healthy nonsmoker ADCglob values were statisti-
cally indistinguishable; P5 0.214 and P5 0.114 for 3He and
129Xe data, respectively.
A strong positive correlation between 3He and 129Xe
ADCglob was found when pooling data from healthy non-
smokers group a, ex-smokers and COPD patients together
(Fig. 4: Spearman’s r5 0.922, P< 0.001). Analyzing the
three subject groups separately, significant correlations
between 3He and 129Xe ADCglob were observed for each of
the three groups (P< 0.05).
MR Metrics vs. PFTs
A summary of the statistical analyses of relationships
between MR metrics and PFTs is presented in Table 3.
Both 3He and 129Xe VV% exhibited significant correlations
with FEV1 and FEV1/FVC at P< 0.001 (except
129Xe
VV% vs. FEV1, P< 0.05 significance level). Correlations of
VV% values derived from both nuclei with DLCO were rela-
tively weaker, although still significant at the P< 0.05 level.
Note: One significant outlying datapoint from a patient
with NSCLC with %-predicted spirometry 90% but low
VV% values, 50% for both nuclei, was excluded from the
analysis presented in Table 3. When these outlying data
were included in the analysis, the correlation statistics were
severely affected; correlations of VV% with DLCO were no
longer significant (P > 0.05) and all other correlations were
significant at the P< 0.05 level, rather than P< 0.001
(Table 3 caption).
ADCglob values also showed strong correlations with
PFTs; notably, correlations of 3He ADCglob with both FEV1
and FEV1/FVC were significant at the P< 0.001 level,
while correlations with DLCO were significant at the
P< 0.05 level (Table 3). Similarly, correlations of 129Xe
ADCglob with FEV1 were significant to P< 0.001, and cor-
relations with FEV1/FVC and DLCO were significant to
P< 0.05.
Repeatability
In COPD patients, both 3He and 129Xe ventilation images
appeared qualitatively similar (in terms of visual ventilation
defect prevalence and ventilation homogeneity) at each of
the four scan timepoints, as shown for a representative
example in Fig. 5. Mean CV values of 3He and 129Xe VV%
between all repeated scans were 4.08% and 13.01%, respec-
tively (Table 4). According to ICC analysis, both 3He VV%
(ICC coefficient 0.541, P5 0.061) and 129Xe VV% (coeffi-
cient 0.458, P5 0.095) repeatability—calculated by consid-
ering data from all scan timepoints—was classified as just
beyond the 95% confidence level. The CV of 3He VV%
was comparable to that of PFTs, while the 129Xe VV% CV
was higher.
Good agreement in the appearance of both 3He and
129Xe ADC maps was observed for each scan timepoint, as
illustrated in Fig. 6. 3He and 129Xe ADCglob values were
highly repeatable over all scan sessions, with ICC coeffi-
cients for interscan agreement (0.995 and 0.936 for 3He
and 129Xe, respectively) significant at the P< 0.001 level,
and mean CV values of <3% in both cases (see Table 4).
FIGURE 3: Representative dataset of 3He and 129Xe ADC maps obtained from a healthy nonsmoker (group a) and a patient with
COPD. The mean ADC over all slices is quoted underneath each dataset.
FIGURE 4: Correlation between mean 3He and 129Xe ADCglob
in healthy nonsmokers (group a), ex-smokers, and patients with
COPD, with associated Spearman’s correlation coefficient (r)
and P value of statistical significance. The dashed line repre-
sents a linear fit to the data and error bars represent the stan-
dard deviation of repeated scans for each COPD patient.
Journal of Magnetic Resonance Imaging
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ICC coefficients and CVs of ADCglob values were compara-
ble to those of FEV1 and FEV1/FVC, and considerably less
than those of DLCO and VV%.
Discussion
This work indicates that 129Xe lung MRI can provide equiv-
alent regional information on lung ventilation and micro-
structure to 3He MRI at to-date the most-reported field
strength for lung MRI, 1.5T. Specifically, we demonstrated
a clear agreement between 129Xe ventilation and diffusion
MRI measurements and 3He equivalent measurements; these
findings substantiate previous work from the Robarts group
that was performed at 3T with lower spatial resolution
imaging.3,15,16 We also quantified the repeatability of 129Xe
ventilation and diffusion-weighted MRI metrics against 3He
equivalent measurements in COPD patients.
3He and 129Xe VV% correlated strongly, with a posi-
tive bias towards increased VV% for 3He. Discrepancies can
likely be attributed to differences in image slice thickness,
gas polarization, and the fundamental properties of the gases
as discussed below. The generally lower VV% of 129Xe may
be explained by the 5-fold lower diffusion coefficient of
xenon in air (as confirmed by the mean ADCs of the two
gases measured in healthy lungs here), and the resulting
slower penetration of partially obstructed airways, although
the relatively lower mean SNR of 129Xe ventilation images
may also contribute to this observation. In patients with
severe disease, partially obstructed airways may cause an
accentuation of this diffusion-related effect, leading to obser-
vation of further ventilation abnormalities with 129Xe when
compared with 3He. We note that a time-dependent diffu-
sive effect of delayed filling of ventilation defects and collat-
eral ventilation has been observed in COPD patients by
3He MRI,31 but the equivalent measurements has not yet
been reported for 129Xe. A reduced VV% for 129Xe when
compared with 3He was also reported previously at 3T3,16
TABLE 3. Correlations Between MRI-Derived 3He and 129Xe VV% and ADC Measurements and PFTs
r (P) 3He ADC 129Xe ADC 3He VV% 129Xe VV%
DLCO (%-pred) 20.537 (0.018
a) 20.628 (0.005a) 0.524c (0.019a) 0.476c (0.035a)
FEV1 (%-pred) (20.724 <0.001
b) 20.834 (<0.001b) 0.732 (<0.001b) 0.648 (0.002a)
FEV1/FVC 20.747 (<0.001
b) 20.672 (0.001a) 0.819 (<0.001b) 0.744 (<0.001b)
aCorrelations at the statistical significance level of P< 0.05.
bCorrelations at the statistical significance level of P< 0.001.
cResults of correlating VV% values with PFTs represent the statistics obtained when outlying data associated with one NSCLC patient
was excluded. When this data-point was included, the correlation coefficients (P values) for VV% altered as follows: 3He, 3 rows:
0.432 (0.052); 0.592 (0.005a); 0.559 (0.012a); 129Xe, 3 rows: 0.387 (0.084); 0.531 (0.012a); 0.529 (0.015a).
%-pred: %-predicted pulmonary function test result.
FIGURE 5: Selected 3He and 129Xe ventilation image slices acquired at each of the four scan timepoints of the repeatability study
from a COPD patient. Calculated ventilated volume percentages (VV%) are quoted underneath each respective set of images.
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and attributed to lower diffusivity. Furthermore, systemati-
cally higher absolute ventilated volumes have been reported
for 3He when compared with 129Xe at 3T,15 wherein it was
suggested that 3He has a higher propensity to flow through
collateral channels in COPD patients. Nevertheless, this
property of 129Xe could prove useful in the assessment of
early (ie, small-scale) structural abnormalities of distal air-
ways and lung parenchyma in a variety of pulmonary dis-
eases, provided that equivalent image SNR and spatial
resolution can be achieved as that of 3He MRI.
The lower CV values (and higher ICC coefficients) of
3He VV% when compared with 129Xe VV% are likely
attributable to the generally lower and more variable SNR
of 129Xe images acquired at the time of the study (mean6
standard deviation of SNR over all NSCLC and COPD
patients: 23.66 16.8 for 129Xe; 30.66 10.8 for 3He), and
the differences in lung inflation level in some cases between
129Xe and anatomical 1H images acquired in a separate
breath-hold.28 As mentioned in the Materials and Methods,
polarization levels, and thus image SNR, affect the ventila-
tion heterogeneity and therefore images with low SNR (<5)
can significantly distort the physiological interpretation of
the data. The relatively lower SNR may be explained by the
fact that a prototype 129Xe polarizer (producing 129Xe polar-
ization 10–15%) was used for most 129Xe experiments in
this work.12 We have since developed and optimized a
clinical-scale polarizer capable of rapidly producing 129Xe
polarized to 40%, which will enable improved 129Xe
image SNR in future studies.27 Nevertheless, the CV of
129Xe VV% is severely biased by an outlying subject (CV of
TABLE 4. Repeatability of PFTs and MRI Metrics in Patients With COPD
ICC (P value) CV mean (%) CV range (%)
FEV1 (%-pred) 0.934 (<0.001
b) 4.22 2.16–6.35
FEV1/FVC 0.987 (<0.001
b) 2.34 1.49–3.80
DLCO (%-pred) 0.992 (<0.001
b) 8.73 3.91–16.15
3He VV% 0.541 (0.061) 4.08 2.21–8.86
129Xe VV% 0.458 (0.095) 13.01 9.62–25.28
3He ADCglob 0.995 (<0.001
b) 2.98 1.48–5.61
129Xe ADCglob 0.936 (<0.001
b) 2.77 1.68–5.88
ICC5 intraclass correlation coefficient; CV5 coefficient of variation.
aStatistical significance level of P< 0.05.
bStatistical significance level of P< 0.001.
FIGURE 6: Representative 3He and 129Xe ADC maps acquired at each of the four scan timepoints of the repeatability study from a
COPD patient. Global mean ADC values (ADCglob) are quoted underneath each respective set of maps.
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25%); the CV in all other COPD patients was 10%. The
129Xe images from the first scan session in this outlying sub-
ject were excluded from analysis because of insufficient
SNR. Despite this observation, no other metrics showed
abnormally high CV for that patient and no differences in
the patient’s clinical status were noted.
The high regional heterogeneity of COPD may
explain the increased CV of VV% when compared with
ADCglob (ADC maps are of lower resolution than ventila-
tion images), although we note that, qualitatively, the prom-
inent areas of ventilation defect were observed repeatedly
over scan sessions. Furthermore, the variability of broncho-
dilator therapy applied on a day-to-day basis will potentially
impact VV% more severely than ADC. Nonetheless, both
3He and 129Xe VV% CV values calculated from COPD
patient data are similar to week-to-week percentage variabil-
ity in FEV1 and DLCO,
32 and same-day 3He VV% variabil-
ity in pediatric CF patients,21 as reported earlier, although
poorer than or comparable to the repeatability of PFTs mea-
sured in the present work. Our ICC values for 129Xe VV%
are considerably lower than same-session (10 minutes apart)
129Xe VDP ICCs reported by Ebner et al23; however, the
differences can potentially be explained by the fact that in
that work, patients did not leave the scanner between scans,
no multisession/multiday data were recorded, and the num-
ber of patients was significantly higher than in the present
work. Otherwise, the results of 129Xe VV% and ADC
repeatability have, to our knowledge, not been previously
reported, and hence our measurements can only be assessed
against literature data for equivalent 3He measurements.
Resolution of some of the issues discussed herein, including
utilization of the higher performance polarizer, should lead
to improvements in the repeatability of 129Xe VV% to a
similar level as 3He, thus facilitating translation to large-
scale clinical studies.
Typically, lower imaging bandwidths and larger diffu-
sion gradients are required for 129Xe when compared with
3He lung MRI, necessitating longer breath-hold times or
lower spatial resolutions. Additionally, until recently, 129Xe
polarizer performance has not been adequate to overcome
the inherent MR signal disadvantages compared with 3He.
As such, a compromise was reached in this work, such that
the in-plane resolution of 129Xe ventilation imaging acquisi-
tions matched that of 3He, but the slice resolution was
halved. Developments in compressed sensing (CS) and par-
allel imaging acquisition strategies for accelerated imag-
ing33,34 should help permit equivalent, isotropic resolution
129Xe, and 3He ventilation imaging within a clinically feasi-
ble breath-hold in the near future, and facilitate same-breath
129Xe and 1H imaging for improved 129Xe ventilation volu-
metry. Moreover, it has recently been demonstrated that 3D
multiple b-value diffusion-weighted CS-based acquisition
strategies for whole-lung morphometric analysis developed
for diffusion-weighted 3He MRI35 are readily transferable to
129Xe.36 Although the through-plane 129Xe ventilation and
diffusion image resolution in this work is already superior
to previous reports at 3T, the adoption of CS methods for
both applications should enable these resolution limits to be
pushed further towards those attainable with 3He.
Mean ADCglob values of both nuclei exhibited excel-
lent correlation with each other and high repeatability in
COPD patients, with comparable or lower interscan CVs
than conventional PFTs, suggesting that 129Xe diffusion-
weighted MR has approximately equal sensitivity to 3He for
quantitative assessment of lung microstructural changes, and
sufficient reliability for routine clinical application.
The observation of elevated ADCglob in COPD
patients agrees with previous reports for both 3He3,26 and
129Xe,6,7 and has been well characterized. Similarly,
increased ADCglob in subjects with smoking history is con-
sistent with previous observations,7 although the 129Xe b-
values used in those works differ from this work. As a con-
sequence of the non-Gaussian phase dispersion of the 3He
and 129Xe diffusion regime experienced in the lungs, ADC-
glob exhibits some variation with b-value,
37 which constrains
the validity of interstudy comparisons. As such, we recom-
mend that for ease of implementation and comparison
across sites, a standardized b-value and diffusion time should
be adopted for 129Xe diffusion-weighted MRI, similar to the
value of 1.6 s.cm22 now widely used for 3He.
CV values of both 3He and 129Xe ADCglob are less
than those of previously reported same-day variability in
FEV1,
32 and substantially lower than measured variability in
DLCO (9%)
38. DLCO is perhaps the most relevant PFT to
compare with ADC, since both measurements rely on gas
diffusion within the alveoli, albeit for studying different
lung physiology. Thus, the observed repeatability is
extremely promising for advancing 129Xe diffusion-weighted
MRI to large-scale multisite trials with the goal of routine
clinical implementation. Additionally, our reported CV val-
ues of both 3He and 129Xe ADCglob are less than
3He ADC
CVs reported for healthy subjects and patients with emphy-
sema at 1.5T,26 and are comparable to 3He CVs measured
at 3T.20
The design of the present study has some limitations
that could be effectively resolved in future studies. Although
a reasonable number of patients were included in this study
(37 in total), repeatability experiments were only performed
on five patients and, thus, a follow-up comprehensive,
repeatability-specific study is required with an increased
number of subjects, including both patients and volunteers.
In such a study, it may be statistically meaningful to distin-
guish same-day from 2-week repeatability, and therefore bet-
ter identify potential sources of physiological variability
between different scan sessions. Due to a few missing data-
sets, the current data is insufficient in quantity for such
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statistically sound intertimepoint repeatability analysis;
hence, the repeatability was only analyzed over all scan ses-
sions. Data regarding day-to-day and week-to-week repeat-
ability is critical for understanding the natural physiological
variability in VV% and ADCglob in patients and discrimi-
nating this from measurement uncertainty.
In conclusion, the findings reported herein demon-
strate that 129Xe is approaching readiness as a clinically via-
ble alternative to 3He for quantitative lung ventilation and
microstructural MRI studies. For future dissemination and
multisite cross-platform clinical trials, the fact that our
results agree with many of the trends seen in prior studies
that benchmarked 3He and 129Xe MRI measurements at 3T
is encouraging. Although quantitative measurements of ven-
tilation and ADC will be biased by magnetic susceptibility
effects at the two field strengths, we believe that equivalent
functional information can be achieved with both gases at
both field strengths. In addition, the high repeatability of
both 3He and 129Xe ADC observed here is perhaps the
most convincing evidence to date that 129Xe ADC imaging
has developed into a robust microstructural imaging meth-
odology. Moreover, this report builds upon previous meas-
urements at 3T in terms of improved spatial resolution of
129Xe imaging, and the realization of 3D DW-MRI with
both nuclei35,36 is extremely promising for further validation
and clinical application in the near future. The preliminary
assessment of the repeatability of 129Xe ventilation and dif-
fusion MRI biomarkers addresses a gap in knowledge that
was not considered prior to this work and paves the way for
further, more comprehensive multisite repeatability studies.
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